Page last updated: 2024-10-22

albuterol and Hyperplasia

albuterol has been researched along with Hyperplasia in 5 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research Excerpts

ExcerptRelevanceReference
"In Colombia, compared with the use of albuterol alone, the use of beclomethasone dipropionate added to albuterol as needed for symptom relief is cost-effective in children 5 to 11 years old with mild intermittent (step 1) asthma, because it involves a higher probability of a lack of a requirement for prednisone for AE at lower total treatment costs."5.51As-Needed Use of Short-Acting β ( Buendia, JA; Rodríguez-Martínez, CE; Sossa-Briceño, MP, 2022)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Rodríguez-Martínez, CE1
Sossa-Briceño, MP1
Buendia, JA1
Kramer, EL2
Madala, SK1
Hudock, KM1
Davidson, C1
Clancy, JP1
Sauer, R1
Griff, S1
Blau, A1
Franke, A1
Mairinger, T1
Grah, C1
Mushaben, EM1
Pastura, PA1
Acciani, TH1
Deutsch, GH1
Khurana Hershey, GK1
Korfhagen, TR1
Hardie, WD1
Whitsett, JA1
Le Cras, TD1
Kamachi, A1
Munakata, M1
Nasuhara, Y1
Nishimura, M1
Ohtsuka, Y1
Amishima, M1
Takahashi, T1
Homma, Y1
Kawakami, Y1

Trials

1 trial available for albuterol and Hyperplasia

ArticleYear
As-Needed Use of Short-Acting β
    The journal of allergy and clinical immunology. In practice, 2022, Volume: 10, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Child

2022

Other Studies

4 other studies available for albuterol and Hyperplasia

ArticleYear
Subacute TGFβ Exposure Drives Airway Hyperresponsiveness in Cystic Fibrosis Mice through the PI3K Pathway.
    American journal of respiratory cell and molecular biology, 2020, Volume: 62, Issue:5

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchoconstriction; Cystic Fibrosis; Goblet Cells; Hy

2020
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia diagnosed by transbronchial lung cryobiopsy: a case report.
    Journal of medical case reports, 2017, Apr-07, Volume: 11, Issue:1

    Topics: Aged; Albuterol; Anti-Inflammatory Agents; Biopsy; Bronchodilator Agents; Budesonide; Cough; Cryosur

2017
Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
    American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:4

    Topics: Airway Resistance; Albuterol; Animals; Bronchial Hyperreactivity; Cells, Cultured; Disease Models, A

2009
Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma.
    Thorax, 2001, Volume: 56, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents; Asthma; Bronchoconstrictor A

2001